1. The impact of cycleanine in cancer research: a computational study
   Ogochukwu Ngozi Nwaefulu et al, 2022, Journal of Molecular Modeling CrossRef
2. Progress on structural modification of Tetrandrine with wide range of pharmacological activities
   Liuying Mo et al, 2022, Frontiers in Pharmacology CrossRef
3. Growth-Suppressive and Apoptosis-Inducing Effects of Tetrandrine in SW872 Human Malignant Liposarcoma Cells via Activation of Caspase-9, Down-Regulation of XIAP and STAT-3, and ER Stress
   Mohammed Samsuzzaman et al, 2022, Biomolecules CrossRef
4. Exploring the recent trends in perturbing the cellular signaling pathways in cancer by natural products
   Md. Mominur Rahman et al, 2022, Frontiers in Pharmacology CrossRef
5. Tetrandrine Enhances Radiosensitization in Human Hepatocellular Carcinoma Cell Lines
   Xiao-mei Zhao et al, 2018, Radiation Research CrossRef
6. Design, Synthesis of Novel Tetrandrine-14-l-Amino Acid and Tetrandrine-14-l-Amino Acid-Urea Derivatives as Potential Anti-Cancer Agents
   Sheng-Cao Hu et al, 2020, Molecules CrossRef
7. Tetrandrine Exerts a Radiosensitization Effect on Human Glioma through Inhibiting Proliferation by Attenuating ERK Phosphorylation
   Ji-wei Ma et al, 2017, Biomolecules & Therapeutics CrossRef
8. Naturally Sourced CDK Inhibitors and Current Trends in Structure-Based Synthetic Anticancer Drug Design by Crystallography
   Sisir Nandi et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
9. Alkaloid Containing Natural Products for Therapeutic Use in Cancer
   A. K. M. Shafiul Kadir et al, 2022, Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics CrossRef
10. Reduction-sensitive Paclitaxel Prodrug Self-assembled Nanoparticles with Tetrandrine Effectively Promote Synergistic Therapy Against Drug-sensitive and Multidrug-resistant Breast Cancer
    Mengjuan Jiang et al, 2017, Molecular Pharmaceutics CrossRef
11. Tetrandrine Induces Early G1 Arrest in Human Colon Carcinoma Cells by Down-Regulating the Activity and Inducing the Degradation of G1-S–Specific Cyclin-Dependent Kinases and by Inducing p53 and p21Cip1
    Ling-hua Meng et al, 2004, Cancer Research CrossRef